Compare ARVN & TALK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARVN | TALK |
|---|---|---|
| Founded | 2015 | 2012 |
| Country | United States | United States |
| Employees | N/A | 521 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 658.2M | 788.5M |
| IPO Year | 2018 | N/A |
| Metric | ARVN | TALK |
|---|---|---|
| Price | $8.95 | $5.19 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 6 |
| Target Price | ★ $15.05 | $6.42 |
| AVG Volume (30 Days) | 858.9K | ★ 1.3M |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 58.84 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $262,600,000.00 | N/A |
| Revenue This Year | N/A | $26.02 |
| Revenue Next Year | N/A | $21.24 |
| P/E Ratio | ★ N/A | $155.55 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.06 | $2.22 |
| 52 Week High | $14.22 | $5.20 |
| Indicator | ARVN | TALK |
|---|---|---|
| Relative Strength Index (RSI) | 37.05 | 55.78 |
| Support Level | $8.72 | $4.59 |
| Resistance Level | $10.18 | $5.20 |
| Average True Range (ATR) | 0.47 | 0.01 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 28.82 | 50.50 |
Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.